Why the study?
Does whole-blood platelet aggregation predict primary hemostatic function differently in elderly versus young blood donors?
Does whole-blood platelet aggregation predict primary hemostatic function differently in elderly versus young blood donors?
Whole-blood platelet aggregation in response to collagen and arachidonic acid may be more useful in predicting primary hemostatic function and coronary risk in the elderly than in the young.
No takes yet. Share an insight, caveat, or question.
May suggest greater utility of aggregation testing for hemostatic function in the elderly; leaves open its role in coronary risk assessment.
Emery et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: